Flagellin/Toll-like receptor 5 response was specifically attenuated by keratan sulfate disaccharide via decreased EGFR phosphorylation in normal human bronchial epithelial cells

Biochemical and Biophysical Research Communications

Volumn 435, Issue 3, 2013, Pages 460-465

  Shirato, Ken ^a,b   Gao, Congxiao ^a   Ota, Fumi ^a   Angata, Takashi ^a   Shogomori, Hidehiko ^a   Ohtsubo, Kazuaki ^a   Yoshida, Keiichi ^a   Lepenies, Bernd ^c   Taniguchi, Naoyuki ^a  

^a RIKEN   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

Author keywords

Airway epithelial cells; Epidermal growth factor receptor; Flagellin; Interleukin 8; Keratan sulfate disaccharide

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FLAGELLIN; INTERLEUKIN 8; KERATAN SULFATE; N ACETYLLACTOSAMINE SYNTHASE; TOLL LIKE RECEPTOR 5;

ARTICLE; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BACTERIAL INFECTIONS; BRONCHI; CELLS, CULTURED; FLAGELLIN; HUMANS; INTERLEUKIN-8; KERATAN SULFATE; PHOSPHORYLATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESPIRATORY MUCOSA; TOLL-LIKE RECEPTOR 5;

BACTERIA (MICROORGANISMS);

EID: 84878990680     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.009     Document Type: Article

References (38)

1. Global strategy for the diagnosis, management and prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). Available from: < 2013. http://www.goldcopd.org/.
2. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., Cherniack R.M., Rogers R.M., Sciurba F.C., Coxson H.O., Pare P.D. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004, 350:2645-2653.
3. Murphy T.F. The many faces of Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Clin. Infect. Dis. 2008, 47:1534-1536.
4. Sethi S., Murphy T.F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 2008, 359:2355-2365.
5. Rosell A., Monsó E., Soler N., Torres F., Angrill J., Riise G., Zalacaín R., Morera J., Torres A. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch. Intern. Med. 2005, 165:891-897.
6. Murphy T.F., Brauer A.L., Eschberger K., Lobbins P., Grove L., Cai X., Sethi S. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2008, 177:853-860.
7. Sethi S., Anzueto A., Farrell D.J. Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis. Ann. Clin. Microbiol. Antimicrob. 2005, 4:5.
8. Sarir H., Henricks P.A., van Houwelingen A.H., Nijkamp F.P., Folkerts G. Cells, mediators and Toll-like receptors in COPD. Eur. J. Pharmacol. 2008, 585:346-353.
9. Raoust E., Balloy V., Garcia-Verdugo I., Touqui L., Ramphal R., Chignard M. Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells. PLoS One 2009, 4:e7259.
10. Sorrentino R., de Souza P.M., Sriskandan S., Duffin C., Paul-Clark M.J., Mitchell J.A. Pattern recognition receptors and interleukin-8 mediate effects of Gram-positive and Gram-negative bacteria on lung epithelial cell function. Br. J. Pharmacol. 2008, 154:864-871.
11. Banerjee D., Khair O.A., Honeybourne D. Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD. Eur. Respir. J. 2004, 23:685-691.
12. Bresser P., Out T.A., van Alphen L., Jansen H.M., Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2000, 162:947-952.
13. Sethi S., Maloney J., Grove L., Wrona C., Berenson C.S. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006, 173:991-998.
14. Soler N., Ewig S., Torres A., Filella X., Gonzalez J., Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur. Respir. J. 1999, 14:1015-1022.
15. Koff J.L., Shao M.X., Kim S., Ueki I.F., Nadel J.A. Pseudomonas lipopolysaccharide accelerates wound repair via activation of a novel epithelial cell signaling cascade. J. Immunol. 2006, 177:8693-8700.
16. Shaykhiev R., Behr J., Bals R. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. PLoS One 2008, 3:e1393.
17. Koff J.L., Shao M.X., Ueki I.F., Nadel J.A. Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium. Am. J. Physiol. Lung Cell Mol. Physiol. 2008, 294:L1068-L1075.
18. Choi H.J., Seo C.H., Park S.H., Yang H., Do K.H., Kim J., Kim H.K., Chung D.H., Ahn J.H., Moon Y. Involvement of epidermal growth factor receptor-linked signaling responses in Pseudomonas fluorescens-infected alveolar epithelial cells. Infect. Immun. 2011, 79:1998-2005.
19. Gao C., Maeno T., Ota F., Ueno M., Korekane H., Takamatsu S., Shirato K., Matsumoto A., Kobayashi S., Kitazume S., Ohtsubo K., Betsuyaku T., Taniguchi N. Sensitivity of heterozygous α1, 6 fucosyltransferase knock out mice to cigarette smoke-induced emphysema: implication of aberrant TGF-β signaling and MMP gene expression. J. Biol. Chem. 2012, 287:16699-16708.
20. Kamio K., Yoshida T., Gao C., Ishii T., Ota F., Motegi T., Kobayashi S., Fujinawa R., Ohtsubo K., Kitazume S., Angata T., Azuma A., Gemma A., Nishimura M., Betsuyaku T., Kida K., Taniguchi N. α1,6 Fucosyltransferase (Fut8) is implicated in vulnerability to elastase-induced emphysema in mice and a possible non-invasive predictive marker for disease progression and exacerbation in chronic obstructive pulmonary disease (COPD). Biochem. Biophys. Res. Commun. 2012, 424:112-117.
21. Asari A., Kanemitsu T., Kurihara H. Oral administration of high molecular weight hyaluronan (900kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium. J. Biol. Chem. 2010, 285:24751-24758.
22. Misra S., Toole B.P., Ghatak S. Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells. J. Biol. Chem. 2006, 281:34936-34941.
23. Johnson G.B., Brunn G.J., Kodaira Y., Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 2002, 168:5233-5239.
24. Monzon M.E., Casalino-Matsuda S.M., Forteza R.M. Identification of glycosaminoglycans in human airway secretions. Am. J. Respir. Cell Mol. Biol. 2006, 34:135-141.
25. Isnard N., Robert L., Renard G. Effect of sulfated GAGs on the expression and activation of MMP-2 and MMP-9 in corneal and dermal explant cultures. Cell Biol. Int. 2003, 27:779-784.
26. Xu H., Kurihara H., Ito T., Kikuchi H., Yoshida K., Yamanokuchi H., Asari A. The keratan sulfate disaccharide Gal(6S03) β1,4-GlcNAc(6S03) modulates interleukin 12 production by macrophages in murine Thy-1 type autoimmune disease. J. Biol. Chem. 2005, 280:20879-20886.
27. Kubota M., Yoshida K., Tawada A., Ohashi M. Characterization of oligosaccharides of the lactosamine series derived from Keratan sulfates by tandem mass spectrometry. Eur. J. Mass. Spectrom. 2000, 6:193-203.
28. Campo G.M., Avenoso A., Campo S., D'Ascola A., Nastasi G., Calatroni A. Molecular size hyaluronan differently modulates toll-like receptor-4 in LPS-induced inflammation in mouse chondrocytes. Biochimie 2010, 92:204-215.
29. Funderburgh J.L. Keratan sulfate: structure, biosynthesis, and function. Glycobiology 2000, 10:951-958.
30. Barton G.M., Kagan J.C. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat. Rev. Immunol. 2009, 9:535-542.
31. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
32. Takeuchi K., Taguchi F., Inagaki Y., Toyoda K., Shiraishi T., Ichinose Y. Flagellin glycosylation island in Pseudomonas syringae pv. glycinea and its role in host specificity. J. Bacteriol. 2003, 185:6658-6665.
33. Verma A., Arora S.K., Kuravi S.K., Ramphal R. Roles of specific amino acids in the N terminus of Pseudomonas aeruginosa flagellin and of flagellin glycosylation in the innate immune response. Infect. Immun. 2005, 73:8237-8246.
34. Brimer C.D., Montie T.C. Cloning and comparison of fliC genes and identification of glycosylation in the flagellin of Pseudomonas aeruginosa a-type strains. J. Bacteriol. 1998, 180:3209-3217.
35. Smith K.D., Andersen-Nissen E., Hayashi F., Strobe K., Bergman M.A., Barrett S.L., Cookson B.T., Aderem A. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 2003, 4:1247-1253.
36. Capila I., Linhardt R.J. Heparin-protein interactions. Angew. Chem. Int. Ed. Engl. 2002, 41:390-412.
37. Jackson R.L., Busch S.J., Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev 1991, 71:481-539.
38. Haglund L., Tillgren V., Onnerfjord P., Heinegard D. The C-terminal peptide of chondroadherin modulates cellular activity by selectively binding to heparan sulfate chains. J. Biol. Chem. 2013, 288:995-1008.